Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Kees

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|January 1, 1989
Perfluoro-N-[4-(1H-tetrazol-5-ylmethyl)phenyl]alkanamides. A new class of oral antidiabetic agentsK L Kees, R S Cheeseman, D H Prozialeck, et al.
Journal of Medicinal Chemistry|November 1, 1986
Synthesis and antiallergic activity of a novel series of 5-lipoxygenase inhibitorsK L Kees, J H Musser, J Chang, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Parallel solid-phase synthesis of vitronectin receptor (alphavbeta3) inhibitorsA Gopalsamy, H Yang, J W Ellingboe, et al.
Journal of Medicinal Chemistry|September 27, 1996
New potent antihyperglycemic agents in db/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and -pyrazolonesK L Kees, J J Fitzgerald, K E Steiner, et al.
Journal of Medicinal Chemistry|March 6, 1992
Perfluorocarbon-based antidiabetic agentsK L Kees, T M Smith, M L McCaleb, et al.
Journal of Medicinal Chemistry|February 17, 1995
Studies on new acidic azoles as glucose-lowering agents in obese, diabetic db/db miceK L Kees, T J Caggiano, K E Steiner, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|January 1, 1989
Perfluoro-N-[4-(1H-tetrazol-5-ylmethyl)phenyl]alkanamides. A new class of oral antidiabetic agentsK L Kees, R S Cheeseman, D H Prozialeck, et al.
Journal of Medicinal Chemistry|November 1, 1986
Synthesis and antiallergic activity of a novel series of 5-lipoxygenase inhibitorsK L Kees, J H Musser, J Chang, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Parallel solid-phase synthesis of vitronectin receptor (alphavbeta3) inhibitorsA Gopalsamy, H Yang, J W Ellingboe, et al.
Journal of Medicinal Chemistry|September 27, 1996
New potent antihyperglycemic agents in db/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and -pyrazolonesK L Kees, J J Fitzgerald, K E Steiner, et al.
Journal of Medicinal Chemistry|March 6, 1992
Perfluorocarbon-based antidiabetic agentsK L Kees, T M Smith, M L McCaleb, et al.
Journal of Medicinal Chemistry|February 17, 1995
Studies on new acidic azoles as glucose-lowering agents in obese, diabetic db/db miceK L Kees, T J Caggiano, K E Steiner, et al.
Pageof 1